
    
      This is a prospective, multicenter, single-masked, randomized clinical trial comparing the
      Hydrus Microstent to two iStent implants for the reduction of intraocular pressure in phakic
      patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative
      glaucoma, or pigmentary dispersion glaucoma. Post-operative follow-up visits will be
      conducted at regular intervals.
    
  